Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
about
Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.Clinical significance of aberrant mammalian target of rapamycin expression in stage IIIB colon cancer.The expression of chemokine receptors CXCR3 and CXCR4 in predicting postoperative tumour progression in stages I-II colon cancer: a retrospective study.Circulating tumor cells as a surrogate marker for determining clinical outcome to mFOLFOX chemotherapy in patients with stage III colon cancer.Quantifying limitations in chemotherapy data in administrative health databases: implications for measuring the quality of colorectal cancer care.Adherence to clinical practice guidelines for adjuvant chemotherapy for colorectal cancer in a Canadian province: a population-based analysisEvaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.Chemoresistance to doxorubicin induces epithelial-mesenchymal transition via upregulation of transforming growth factor β signaling in HCT116 colon cancer cells.GATA2 rs2335052 Polymorphism Predicts the Survival of Patients with Colorectal Cancer.Adjuvant systemic chemotherapy for stages II and III colon cancer after complete resection: a clinical practice guidelineAdjuvant chemotherapy in rectal cancer: defining subgroups who may benefit after neoadjuvant chemoradiation and resection: a pooled analysis of 3,313 patientsOverview of systemic therapy for colorectal cancer.Better colon cancer care for extremely poor Canadian women compared with American women.Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles.Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Colon Cancer.Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumours.Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry.Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study.Synergistic interaction between galectin-3 and carcinoembryonic antigen promotes colorectal cancer metastasis.Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.Factors predicting worse prognosis in patients affected by pT3 N0 colon cancer: long-term results of a monocentric series of 137 radically resected patients in a 5-year period.The role of adjuvant chemotherapy in stage II colorectal cancer patients.Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.Prognostic and predictive value of the macroscopic growth pattern in patients undergoing curative resection of colorectal cancer: a single-institution retrospective cohort study of 4,080 Chinese patients.
P2860
Q33432180-BD37E159-C3BE-4430-9A90-9F1F20FD0F8BQ33968034-BFDDEF7E-5F6C-4880-AAFD-D2E008EF126EQ34071833-63E46F08-3DF9-40A6-AB10-3254E01CE614Q34328567-2CD3993B-7E83-4AD0-8F27-7FDE25CE8DD3Q34360966-957B9029-91F5-4C29-97C0-AA6E68CB1D55Q34488296-7291E2D1-DFBD-4BF9-8399-D367C42C39F8Q35067307-D47100D9-70CE-415F-BC4F-188D945C4A6BQ35628337-AB1DD75A-59B5-49D3-A7B4-6D0CA18CC81CQ35750225-4354EFC8-4292-46E3-9EFB-21CB64F1B9F6Q36239072-BD2DACC4-9FE0-4D16-B1CD-7B5D651CF200Q37119089-A7B052F5-9D3D-4446-B049-8A5B531FB080Q37484326-AD9966A8-C9AB-42D5-8B10-02621082DDB1Q37637024-D3F0FBF5-4A59-4826-A086-8735572D5D65Q37644543-95537351-4CB4-437B-A044-3EA920AE0F72Q38717321-C93CB57A-86C2-4087-9AB7-5473C3FF15D9Q38999686-8C4D0462-D7B4-473A-A49D-FAC8F956A956Q39124451-B01CC6D0-C75C-45C2-A94B-3257C54FF0E0Q39299445-485E9DA3-3BE7-4667-80FB-919B62E0D00FQ40860302-E9265373-7389-4E25-8E14-C4E78D39E52AQ42241513-3238D2A6-2022-408C-BEB7-45B488E0BD69Q47196982-DB726032-F3D3-469B-A166-9C1E73F191B8Q47247356-CFFF851A-D8B5-445B-B686-66067D37307DQ48254485-AC03C024-435C-4B13-8A59-85ED98D51EB3Q53579641-6311D340-7FF4-43A7-996E-1395BF338415Q54232902-53EBA1F8-AE9C-4273-800C-081E79A796A1Q55667758-E773FE46-3D65-49BB-9591-9DD8F5BE64CD
P2860
Adjuvant systemic chemotherapy for Stage II and III colon cancer after complete resection: an updated practice guideline.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adjuvant systemic chemotherapy ...... an updated practice guideline.
@en
Adjuvant systemic chemotherapy ...... an updated practice guideline.
@nl
type
label
Adjuvant systemic chemotherapy ...... an updated practice guideline.
@en
Adjuvant systemic chemotherapy ...... an updated practice guideline.
@nl
prefLabel
Adjuvant systemic chemotherapy ...... an updated practice guideline.
@en
Adjuvant systemic chemotherapy ...... an updated practice guideline.
@nl
P2093
P1433
P1476
Adjuvant systemic chemotherapy ...... an updated practice guideline.
@en
P2093
D J Jonker
Gastrointestinal Cancer Diseas ...... Program in Evidence-based Care
K Spithoff
P304
P356
10.1016/J.CLON.2011.02.010
P577
2011-03-11T00:00:00Z